Yahoo Finance Medtecs International Reports Full Year 2022 Earnings
Medtecs International (Catalist:546) Full Year 2022 Results
Key Financial Results
Revenue: US$56.9m (down 61% from FY 2021).
Net loss: US$28.5m (down by 265% from US$17.3m profit in FY 2021).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Medtecs International shares are down 12% from a week ago.
Risk Analysis
It is worth noting though that we have found 3 warning signs for Medtecs International (1 can't be ignored!) that you need to take into consideration.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Join A Paid User Research Session
You’ll receive a US$30 Amazon Gift card for 1 hour of your time while helping us build better investing tools for the individual investors like yourself. Sign up here
